MENU
+Compare
OPORF
Stock ticker: OTC
AS OF
Jan 2 closing price
Price
$0.09
Change
-$0.15 (-62.50%)
Capitalization
59.97M

OPORF OPEN ORPHAN PLC. Forecast, Technical & Fundamental Analysis

hVIVO PLC is a European-focused, rare, and orphan drug consulting services platform... Show more

OPORF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for OPORF with price predictions
Jan 14, 2026

OPORF sees its 50-day moving average cross bearishly below its 200-day moving average

The 50-day moving average for OPORF moved below the 200-day moving average on January 02, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on January 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on OPORF as a result. In of 6 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

OPORF moved below its 50-day moving average on January 02, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for OPORF crossed bearishly below the 50-day moving average on January 02, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 4 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.010) is normal, around the industry mean (27.929). P/E Ratio (8.329) is within average values for comparable stocks, (51.397). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.899). Dividend Yield (0.031) settles around the average of (0.055) among similar stocks. P/S Ratio (0.861) is also within normal values, averaging (329.547).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OPORF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. OPORF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

View a ticker or compare two or three
OPORF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
42, New Road
Phone
N/A
Employees
210
Web
https://www.hvivo.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UURAF6.100.46
+8.16%
Ucore Rare Metals, Inc.
TERRF10.03N/A
N/A
Terna Rete Elettrica Nazionale SPA
HPTO0.15N/A
N/A
hopTo Inc.
LABFF90.61N/A
N/A
LABORATORIOS FARMACEUTICOS ROVI SA
APXIF11.99N/A
N/A
APx Acquisition Corp. I

OPORF and Stocks

Correlation & Price change

A.I.dvisor tells us that OPORF and ENTX have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OPORF and ENTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OPORF
1D Price
Change %
OPORF100%
N/A
ENTX - OPORF
31%
Poorly correlated
+11.64%
PMN - OPORF
23%
Poorly correlated
-0.25%
EWTX - OPORF
6%
Poorly correlated
+12.91%
BCTX - OPORF
4%
Poorly correlated
-55.49%
GANX - OPORF
3%
Poorly correlated
-1.35%
More